Website
http://dataportal.arc.gov.au/NCGP/API/grants/LP120100606
Funding Status
Closed
Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the Feedback Form.
Funded Activity Summary
The development of a potent new passive immunotherapeutic for the treatment and prevention of bacterial sepsis and septic shock. Bacterial sepsis and septic shock is a leading cause of death in hospital intensive care units and represents a significant public health burden. By developing a new passive immunotherapeutic regimen to treat and prevent bacterial sepsis and septic shock, the project aims to reverse the significant mortality and morbidity associated with this condition.Funded Activity Details
Start Date: 01-2013
End Date: 02-2016
Funding Scheme: Linkage Projects
Funding Amount: $183,000.00
Funder: Australian Research Council
Research Topics
ANZSRC Field of Research (FoR)
Preventive Medicine | Applied Immunology (incl. Antibody Engineering, Xenotransplantation and T-cell Therapies) | Public Health and Health Services
ANZSRC Socio-Economic Objective (SEO)
Clinical Health (Organs, Diseases and Abnormal Conditions) not elsewhere classified | Human Biological Preventatives (e.g. Vaccines) |
